Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jaimie Z Shing"'
Autor:
Jaimie Z. Shing, Carolina Porras, Maísa Pinheiro, Rolando Herrero, Allan Hildesheim, Danping Liu, Mitchell H. Gail, Byron Romero, John T. Schiller, Michael Zúñiga, Sambit Mishra, Laurie Burdette, Kristine Jones, John Schussler, Rebeca Ocampo, Jianwen Fang, Zhiwei Liu, Douglas R. Lowy, Sabrina H. Tsang, Ana Cecilia Rodríguez, Mark Schiffman, Cameron B. Haas, Loretto J. Carvajal, Jalen R. Brown, Aimée R. Kreimer, Lisa Mirabello, Costa Rica HPV Vaccine Trial (CVT) Group
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be af
Externí odkaz:
https://doaj.org/article/34f39d3bc9f746019ec00687f85c2a66
Autor:
Rachel S. Chang, Jaimie Z. Shing, Jennifer C. Erves, Liping Du, Tatsuki Koyama, Stephen Deppen, Alyssa B. Rentuza, Caree McAfee, Christine Stroebel, Janet Cates, Lora Harnack, David Andrews, Robert Bramblett, Pamela C. Hull
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Assessment and feedback is a common implementation strategy to improve healthcare provider fidelity to clinical guidelines. For immunization guidelines, fidelity is often measured with doses administered during eligible visits. Ad
Externí odkaz:
https://doaj.org/article/eb9d9ba2c9f44e4c857d94621d70c0dd
Autor:
Sabrina H. Tsang, John T. Schiller, Carolina Porras, Troy J. Kemp, Rolando Herrero, John Schussler, Monica S. Sierra, Bernal Cortes, Allan Hildesheim, Douglas R. Lowy, Ana Cecilia Rodríguez, Byron Romero, Nicolas Çuburu, Jaimie Z. Shing, Ligia A. Pinto, Joshua N. Sampson, Aimée R. Kreimer, on behalf of the Costa Rica HPV Vaccine Trial Group
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-9 (2022)
Abstract The HPV vaccine has shown sustained efficacy and consistent stabilization of antibody levels, even after a single dose. We defined the HPV16-VLP antibody avidity patterns over 11 years among women who received one- or three doses of the biva
Externí odkaz:
https://doaj.org/article/d8d0fcb1cc4f4e61b568dfc53679c2e8
Autor:
Jaimie Z. Shing, Pamela C. Hull, Yuwei Zhu, Julia W. Gargano, Lauri E. Markowitz, Angela A. Cleveland, Manideepthi Pemmaraju, Ina U. Park, Erin Whitney, Edward F. Mitchel, Marie R. Griffin
Publikováno v:
Papillomavirus Research, Vol 7, Iss , Pp 141-149 (2019)
Introduction: Evidence of human papillomavirus (HPV) vaccine impact on anogenital warts (AGWs) by race or urbanicity in the US is lacking. We evaluated HPV vaccine impact in Tennessee by assessing AGW trends among Tennessee Medicaid (TennCare) enroll
Externí odkaz:
https://doaj.org/article/a1f876a6554142eb80d69b7f9e700c6b
Autor:
Loretto J. Carvajal, Jaimie Z. Shing, Juan C. Vanegas, Emmanuel González, Diego Guillén, Mónica S. Sierra, Allan Hildesheim, Carolina Porras, Rolando Herrero, Guillermo Torres, Meredith S. Shiels, Alejandro Calderón, Aimée R. Kreimer
Publikováno v:
International Journal of Cancer. 152:2052-2060
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3358
Despite radiation therapy (RT) and surgery being the curative treatments, prior work demonstrated that the aggregated Asian American (AA) and Native Hawaiian and Other Pacific Islanders (NHPI) population refuse RT and surgery at a higher rates than o
Autor:
Jaimie Z Shing, Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N Sampson, John Schussler, John T Schiller, Douglas R Lowy, Mónica S Sierra, Loretto Carvajal, Aimée R Kreimer, Bernal Cortés, Paula González, Silvia E. Jiménez, Ana Cecilia Rodríguez, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark Sherman, Sholom Wacholder, Ligia A. Pinto, Troy J. Kemp, Mary K. Sidawy, Wim Quint, Leen-Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler
Publikováno v:
Lancet Oncol
In women vaccinated against human papillomavirus (HPV), reductions in cervical disease and related procedures results in more women having intact transformation zones, potentially increasing the risk of cervical lesions caused by non-vaccine-preventa
Autor:
Jaimie Z Shing, Jereme Corbin, Aimée R Kreimer, Loretto J Carvajal, Kekoa Taparra, Meredith S Shiels, Jacqueline B Vo
Publikováno v:
JNCI Cancer Spectrum. 7
BackgroundAsian Americans and Native Hawaiians and other Pacific Islanders have suboptimal human papillomavirus (HPV) vaccination and cancer screening rates. Asian Americans and NHPIs are often aggregated, masking disparities characterized by varying
Autor:
Pamela C. Hull, James C. Slaughter, Marie R. Griffin, Edward F. Mitchel, Manideepthi Pemmaraju, Staci L. Sudenga, Jaimie Z. Shing, Alicia Beeghly-Fadiel, Rachel S. Chang
Publikováno v:
Am J Prev Med
Introduction Demonstrating human papillomavirus vaccine impact is critical for informing guidelines to increase vaccination and decrease human papillomavirus‒related outcomes, particularly in states with suboptimal vaccination coverage, such as Ten
Autor:
Kekoa Taparra, Brandon I. Ing, Agnes Ewongwo, Jacqueline B. Vo, Jaimie Z. Shing, Megan Y. Gimmen, Kiana M. K. Keli‘i, Jason Uilelea, Erqi Pollom, Elizabeth Kidd
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2571
Brachytherapy improves clinical outcomes among women diagnosed with cervical and endometrial cancers. Recent evidence demonstrates that declining brachytherapy boosts for women with cervical cancer were associated with higher mortality. In this retro